Grant: Therapeutic potential and mechanisms of antitumor activity of proteasome inhibitor bortezomib in extranodal NK/T-cell lymphoma, nasal type

  • Basic View
  • XML View
Project Title
Therapeutic potential and mechanisms of antitumor activity of proteasome inhibitor bortezomib in extranodal NK/T-cell lymphoma, nasal type
 
Principal Investigator Srivastava, Gopesh (Principal investigator)
Co-Investigator(s) Liang, Raymond Hin Suen (Co-Investigator)
Project Code
HKU 7627/06M
 
Funding Year
2006/2007
 
Amount
1229500
 
Start Date
01-09-2006
 
Expected Completion
31-08-2009
 
Status
Completed
 
Keywords NL, NK/T-cell lymphoma
Discipline Pathology, Blood/Hematology
Sponsor RGC General Research Fund (GRF)
Grant Type/Funding Scheme General Research Fund (GRF)
Duration
36
 
Publication Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells
[Coming Soon]